1. Home
  2. AHH vs KALV Comparison

AHH vs KALV Comparison

Compare AHH & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHH
  • KALV
  • Stock Information
  • Founded
  • AHH 1979
  • KALV N/A
  • Country
  • AHH United States
  • KALV United States
  • Employees
  • AHH N/A
  • KALV N/A
  • Industry
  • AHH Real Estate
  • KALV Biotechnology: Pharmaceutical Preparations
  • Sector
  • AHH Finance
  • KALV Health Care
  • Exchange
  • AHH Nasdaq
  • KALV Nasdaq
  • Market Cap
  • AHH 557.9M
  • KALV 642.3M
  • IPO Year
  • AHH 2013
  • KALV N/A
  • Fundamental
  • Price
  • AHH $7.07
  • KALV $14.31
  • Analyst Decision
  • AHH Strong Buy
  • KALV Strong Buy
  • Analyst Count
  • AHH 3
  • KALV 9
  • Target Price
  • AHH $8.83
  • KALV $26.29
  • AVG Volume (30 Days)
  • AHH 1.2M
  • KALV 2.0M
  • Earning Date
  • AHH 08-04-2025
  • KALV 07-10-2025
  • Dividend Yield
  • AHH 11.65%
  • KALV N/A
  • EPS Growth
  • AHH 9.49
  • KALV N/A
  • EPS
  • AHH 0.10
  • KALV N/A
  • Revenue
  • AHH $627,963,000.00
  • KALV N/A
  • Revenue This Year
  • AHH N/A
  • KALV N/A
  • Revenue Next Year
  • AHH $2.11
  • KALV $347.19
  • P/E Ratio
  • AHH $72.97
  • KALV N/A
  • Revenue Growth
  • AHH N/A
  • KALV N/A
  • 52 Week Low
  • AHH $6.10
  • KALV $7.30
  • 52 Week High
  • AHH $12.46
  • KALV $16.32
  • Technical
  • Relative Strength Index (RSI)
  • AHH 50.69
  • KALV 58.58
  • Support Level
  • AHH $6.90
  • KALV $11.10
  • Resistance Level
  • AHH $7.12
  • KALV $16.32
  • Average True Range (ATR)
  • AHH 0.18
  • KALV 1.10
  • MACD
  • AHH 0.01
  • KALV 0.36
  • Stochastic Oscillator
  • AHH 55.43
  • KALV 68.95

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company, which focuses on the discovery, development, and commercialization of small molecule protease inhibitors for a range of diseases. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema and diabetic macular edema; and oral plasma kallikrein inhibitors. Geographically it operates throughout the region of the United States. The company is also conducting preclinical development on a novel, oral, Factor XIIa inhibitor program.

Share on Social Networks: